ArticleFrontiers in microbiology2026
Distribution and antimicrobial resistance profiles of common blood culture isolates in a maternal and child health specialty hospital, Shenzhen (January 2021-October 2025), China.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the distribution and antimicrobial resistance profiles of pathogens causing bloodstream infections (BSIs) in a maternal and child health hospital, providing evidence for rational clinical therapy. Methods: A retrospective analysis was conducted on 395 bacterial isolates recovered from positive blood cultures of inpatients at Longgang District Maternity & Child Healthcare Hospital of Shenzhen City between January 1, 2021 and October 31, 2025. Duplicate isolates from the same patient were excluded. Results: Among all isolates, Gram-positive bacteria accounted for 60.5% and Gram-negative bacteria for 39.5%. Coagulase-negative staphylococci (40.3%) were the most frequently detected, although many were likely contaminants. The major clinically relevant pathogens were Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.